HopeStage
Back to all studies
RecruitingNCT04751331

Brain response to a temporary inflammation challenge in depression

About this titleRead the official source — NCT04751331
Placebo comparisonAges 18–65United States
The study in practice

Understand this study

Who could participate?

Listed age limits: 18 years to 65 years.

Study phase
Phase 1 / Phase 2This study spans more than one phase, so it may combine goals such as safety, dosing, and early effectiveness.

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: May 15, 2021
Recruitment status
Recruiting
Enrollment listed in the registry
180
Sponsor
Laureate Institute for Brain Research, Inc.
Sponsor type
Research institute
Study type
Biological
Intervention type
BIOLOGICAL
Study phase
Phase 1 / Phase 2This study spans more than one phase, so it may combine goals such as safety, dosing, and early effectiveness.
Locations
United States
Age range
From 18 Years to 65 Years
Official registry ID
NCT04751331
Official title
Show the full official title

Neural Response to Inflammatory Challenge in Major Depressive Disorder

Recruitment & locations

Currently recruiting

Tulsa

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Laureate Institute for Brain Research, Inc., a research institute.

Who can participate?

Listed age limits: 18 years to 65 years.

Is this study still recruiting?

The registry lists this study as recruiting.

Want to explore more studies?

Explore studies